Implications of TRILUMINATE, a randomized clinical trial of transcatheter repair for tricuspid regurgitation

PCR Perspectives

Summary

Listen to Nicole Karam and Fabien Praz talk about the latest update from the TRILUMINATE study, the very first randomized trial conducted to determine how to improve the prognosis of tricuspid regurgitation.

To do so, the study aimed at comparing optimal medical treatment with interventions with edge-to-edge repair.

The content of this video was filmed at #EuroPCR 2023. See more videos here